Life Science

LEBSC is an innovative startup that deals with research and development for the creation of innovative materials, biomaterials and micro- and nano materials in the chemical, biomedical, environmental, dental, cosmetic fields. LEBSC uses innovative techniques of synthesis that allow to obtain new materials with characteristics identical to those that are available in nature.

LEBSC provides chemical, chemical and physical, environmental, asbestos and microbiological analysis.

LEBSC designed two innovative systems:

The Total Training s.r.l. is the first innovative startup in the amateur and professional endurance sports sector.

The Total Training services are aimed at:

Transmed Research s.r.l. is a social enterprise based in Ozzano dell’Emilia (BO) whose profits are entirely re-invested in scientific equipment and research activities. It operates as part of the Bologna-Ozzano Science Park, together with a few laboratories of the High Tech Regional Network focused on the life sciences.

SCENT S.r.l (SemiConductor-based Electronic Network for Tumors) is a company whose mission is to design, test, manufacture and market screening tools for detection of tumor formations and pathologies through the analysis of chemical variations in the composition of the gases produced by human organism.

Cellply is a biotechnology company that develops scientific tools automating cell-based functional assays whose aim is to deeply characterize the mode of action of both approved and novel anti-cancer drugs, being able to evaluate the heterogeneity in function of both immune and tumor cells with a single-cell resolution.

The idea for this business arose from the need for a safe and simple way to wash disabled and bedridden people, and the identification of a highly innovative solution to permanently eradicate the problem.

Angiodroid is a startup that was founded in July 2013 by SparkBio and funded by the venture capital fund Zernike Meta Ventures and Emilia Romagna's Ingenium Fund.

Angiodroid designs, manufactures and sells automatic injectors for the injection of carbon dioxide as a contrast material in angiography.

The technology is patented in Italy and abroad to safeguard the uniqueness of the solutions offered to the market (injectors and materials).